BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7242619)

  • 1. Prednisolone in HBsAg-positive chronic active hepatitis.
    N Engl J Med; 1981 Jul; 305(5):281-3. PubMed ID: 7242619
    [No Abstract]   [Full Text] [Related]  

  • 2. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis.
    Lam KC; Lai CL; Trepo C; Wu PC
    N Engl J Med; 1981 Feb; 304(7):380-6. PubMed ID: 7005678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis.
    Nouri-Aria KT; Hegarty JE; Alexander GJ; Eddleston AL; Williams R
    N Engl J Med; 1982 Nov; 307(21):1301-4. PubMed ID: 6215581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoids in therapy of HBs-positive viral hepatitis].
    Mansurov KhKh; Eĭtsen EF; Mirodzhov GK
    Ter Arkh; 1981; 53(10):97-101. PubMed ID: 7313973
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic active hepatitis. Good news and bad news.
    Redeker AG
    N Engl J Med; 1981 Feb; 304(7):420-1. PubMed ID: 7453757
    [No Abstract]   [Full Text] [Related]  

  • 7. [Should chronic active viral hepatitis be treated with drugs or not?].
    Schalm SW
    Internist (Berl); 1981 Dec; 22(12):717-20. PubMed ID: 7033161
    [No Abstract]   [Full Text] [Related]  

  • 8. Levamisole treatment of acute viral hepatitis and HBsAG-positive chronic active hepatitis.
    Pár A; Barna K; Bajtai G; Hollós I; Ambrus M; Kovács M; Jávor T
    Acta Med Acad Sci Hung; 1980; 37(3):269-81. PubMed ID: 7457030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
    Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiviral therapy of HBsAg positive chronic hepatitis: progress or erroneous development?].
    Hess G
    Med Klin (Munich); 1987 May; 82(11):419-20. PubMed ID: 3600545
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiviral therapy in HBsAg-positive chronic liver disease (HBsAg+ve CLD): how many patients really need it?
    Ascione A; Amitrano L; Riccio E; De Lella A; Canestrini C; de Bellis G; D'Alessandro R; Fiore R; Padulano P
    Hepatogastroenterology; 1984 Jun; 31(3):123-4. PubMed ID: 6469200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic lymphocytic leukemia].
    Lim SM; Jang JW; Kim BW; Choi H; Choi KY; Park SJ; Han CW
    Korean J Hepatol; 2008 Jun; 14(2):213-8. PubMed ID: 18617769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of delta antigen in liver biopsies of HBsAg positive patients with chronic liver diseases living in the Naples area.
    Picciotto L; Abrescia N; Ciampi R
    Boll Soc Ital Biol Sper; 1983 Jan; 59(2):189-91. PubMed ID: 6860493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problem of chronic hepatitis (classification, pathogenesis and treatment].
    Podymova SD
    Klin Med (Mosk); 1991 Jun; 69(6):9-13. PubMed ID: 1774926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J; Loch T; Babiuch L; Dabrowska-Bernstein B; Stasiak A; Dabrowski M; Pawińska A
    Pol Tyg Lek; 1988 Sep; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract]   [Full Text] [Related]  

  • 16. [Strategies in the therapy of hepatitis B surface antigen (HBsAg-)-positive chronic hepatitis].
    Hess G; Meyer zum Büschenfelde KH
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1933-7. PubMed ID: 2430769
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased circulating Ia-bearing T cells in HBsAg-positive chronic active hepatitis.
    Pignata C; Vajro P; Troncone R; Monaco G; Ciriaco M
    N Engl J Med; 1982 Aug; 307(8):501-2. PubMed ID: 6980371
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP; Lepiorz H; Berthold H; Gerok W
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of chronic active hepatitis.
    Sherlock S
    Med Times; 1977 Apr; 105(4):83-91, 95-7. PubMed ID: 846337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.